already registered?


register now!

Editorial
Cardiovascular cell therapy: lost in translation? Moving from autologous to allogeneic therapy
Hill J.
EuroIntervention Supplements (2007) 2 (Supplement B) B5-B7
Basic knowledge
Trafficking of stem/progenitor cells after myocardial injury
Wojakowski W., Kucia M., Korzeniowska B., Ratajczak M., Tendera M.
EuroIntervention Supplements (2007) 2 (Supplement B) B9-B15
Bone marrow mesenchymal stem cells and cardiac regeneration
Bartunek J., Hill J., Behfar A., Wijns W., Vanderheyden M., Willemsen P., de Lavareille A., Faber B., Heyndrickx G., Terzic A.
EuroIntervention Supplements (2007) 2 (Supplement B) B16-B21
Umbilical cord blood derived stem cells
Moelker A., Wever K., Cornelissen J., Duncker D., van der Giessen W.J.
EuroIntervention Supplements (2007) 2 (Supplement B) B22-B25
Adipose derived stem cells: new kids on the block
Meliga E., Duckers H., van Geuns R.-J., Regar E., de Jaegere P., van der Giessen W.J., Serruys P.W.
EuroIntervention Supplements (2007) 2 (Supplement B) B26-B32
Delivery techniques and self imaging
Percutaneous cell delivery techniques: devices and issues
Sherman W., Martens T., Ketner W., Siminiak T.
EuroIntervention Supplements (2007) 2 (Supplement B) B33-B41
Magnetically supported procedures and cardiac regeneration
Patterson M., Duckers E., Ramcharitar S., Meliga E., van Weenen S., Maugenest A.-M., Perin E., Serruys P.W.
EuroIntervention Supplements (2007) 2 (Supplement B) B42-B46
The role of magnetic resonance imaging in tracking cardiac stem cell transplantation
Graham J., Hill J., Dick A.
EuroIntervention Supplements (2007) 2 (Supplement B) B47-B54
Clinical status and controversies
What would convince us – From bench to bedside and back
Villa A., Sánchez P., Sanz R., Domí­nguez M., Fernández-Avilés F.
EuroIntervention Supplements (2007) 2 (Supplement B) B55-B59
How to predict recovery after cell therapy in post-MI patients?
Lipiecki J., Durel N., Siminiak T., Ponsonnaille J.
EuroIntervention Supplements (2007) 2 (Supplement B) B60-B65
Persistent angina in “no option” patients with advanced coronary artery disease
Fuchs S., Battler A., Kornowski R.
EuroIntervention Supplements (2007) 2 (Supplement B) B66-B70
Clinical experience with autologous myoblast transplantation
Meliga E., Duckers H., Spencer R., Kalmucki P., Serruys P.W., Siminiak T.
EuroIntervention Supplements (2007) 2 (Supplement B) B71-B78
Intracoronary administration of cells derived from bone marrow in acute myocardial infarction. Ready for clinical use? Lessons from the ASTAMI trial
Lunde K., Aakhus S., Solheim S., Arnesen H., Egeland T., Forfang K.
EuroIntervention Supplements (2007) 2 (Supplement B) B79-B83
Rationale and interim analysis data from the SEISMIC study
Meliga E., Duckers H., Spencer R., Serruys P.W., on behalf of the SEISMIC Investigators
EuroIntervention Supplements (2007) 2 (Supplement B) B84-B88
Future trends: cell engineering for cardiac repair
Fiszer D., Seidel M., Siminiak T., Kurpisz M.
EuroIntervention Supplements (2007) 2 (Supplement B) B89-B94
Framework towards optimisation of bone marrow stem cells therapy for cardiac repair
Vanderheyden M., Heyndrickx G., Wijns W., Bartunek J.
EuroIntervention Supplements (2007) 2 (Supplement B) B95-B98


Back